Table: begin end state 1 18 cytoplasmic 19 53 transmembrane 54 60 cytoplasmic 61 75 transmembrane 76 107 cytoplasmic 108 132 transmembrane 133 137 non-cytoplasmic 138 162 transmembrane 163 168 cytoplasmic 169 188 transmembrane 189 201 non-cytoplasmic 202 220 transmembrane 221 252 cytoplasmic 253 279 transmembrane 280 317 non-cytoplasmic 318 342 transmembrane 343 353 cytoplasmic 354 380 transmembrane 381 385 non-cytoplasmic 386 405 transmembrane 406 410 cytoplasmic 411 429 transmembrane 430 464 non-cytoplasmic 465 487 transmembrane 488 501 cytoplasmic
Input: >WP_042119327.1 NCBI__GCF_000092045.1:WP_042119327.1 MDLFSNLALGFATAATLDNLLFCLIGVLLGTLIGVLPGIGATATIAMLLPITFQLEPVSS LIMLAGIYYGAQYGGSTTAILINMPGESSSAVTAIDGYQMARKGRAGAALAIAALGSFFA GTVSTFLVAIFAPPLTDIALQFGSAEYFSLMIVGLVSSIALAHGSVVKALAMVALGLLLG LVGTDIYTGTPRFTLGIREYADGLNFVALAVGVFGVAEILRNLEGESTRTVLMAKVSGLL PSRQEFKEMIAPIIRGTAIGSALGILPGGGAILASFASYTVEKRLSKTPKEFGQGAVAGV AGPESANNAGAQTSFIPLLTLGIPANPVMALMIGAMIIQGIVPGPNVATEQPALFWGIIA SMWIGNLMLVILNLPLIGLWVKLLTVPYYVLFPIIMAFCSIGVYSVNSNVYDLYAVAFFG LIGYVLAKLRCEPAPLLLGFVLGPLLEENLRRAMILSRGDPSTFITRPISATLLAIAVAV LIVVFLPSVRKKREEVFVEEA
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server